Found: 109
Select item for more details and to access through your institution.
Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques.
- Published in:
- 2007
- By:
- Publication type:
- journal article
External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 9, p. 1368, doi. 10.3390/pharmaceutics13091368
- By:
- Publication type:
- Article
Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 759, doi. 10.3390/vaccines10050759
- By:
- Publication type:
- Article
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.889138
- By:
- Publication type:
- Article
Risk of severe and opportunistic infections and the impact of SARS‐COV‐2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. 800, doi. 10.1111/apt.17393
- By:
- Publication type:
- Article
Resolution of dominant patient‐reported outcome at end of induction predicts clinical and endoscopic remission in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 9, p. 1151, doi. 10.1111/apt.16805
- By:
- Publication type:
- Article
Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 1040, doi. 10.1111/apt.16866
- By:
- Publication type:
- Article
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1442, doi. 10.1111/apt.16626
- By:
- Publication type:
- Article
Interleukin 13 and its role in gut defence and inflammation.
- Published in:
- Postgraduate Medical Journal, 2013, v. 89, n. 1054, p. 448, doi. 10.1136/postgradmedj-2012-303461rep
- By:
- Publication type:
- Article
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 123, doi. 10.1159/000449092
- By:
- Publication type:
- Article
Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0120299
- By:
- Publication type:
- Article
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0060094
- By:
- Publication type:
- Article
Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease.
- Published in:
- PLoS ONE, 2009, v. 4, n. 2, p. 1, doi. 10.1371/journal.pone.0004496
- By:
- Publication type:
- Article
Regulatory Effects of 1α,25-Dihydroxyvitamin D<sub>3</sub> on the Cytokine Production of Human Peripheral Blood Lymphocytes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1999, v. 84, n. 10, p. 3739, doi. 10.1210/jcem.84.10.6054
- By:
- Publication type:
- Article
Tofacitinib in the treatment of ulcerative colitis: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH).
- Published in:
- Wiener Klinische Wochenschrift, 2023, v. 135, n. 1/2, p. 1, doi. 10.1007/s00508-022-02110-2
- By:
- Publication type:
- Article
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 14, p. 4853, doi. 10.3390/jcm12144853
- By:
- Publication type:
- Article
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 18, p. N.PAG, doi. 10.3390/jcm11185308
- By:
- Publication type:
- Article
Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 12, p. 3316, doi. 10.3390/jcm11123316
- By:
- Publication type:
- Article
Quantitative relationship between infliximab exposure and inhibition of C‐reactive protein synthesis to support inflammatory bowel disease management.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 5, p. 2374, doi. 10.1111/bcp.14648
- By:
- Publication type:
- Article
A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 1, p. 101, doi. 10.1111/bcp.12589
- By:
- Publication type:
- Article
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.
- Published in:
- Wiener Klinische Wochenschrift, 2007, v. 119, n. 17/18, p. 519, doi. 10.1007/s00508-007-0841-0
- By:
- Publication type:
- Article
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 5, p. 832, doi. 10.1111/jgh.15828
- By:
- Publication type:
- Article
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0233781
- By:
- Publication type:
- Article
Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study.
- Published in:
- Journal of Rheumatology, 2022, v. 49, n. 3, p. 320, doi. 10.3899/jrheum.210888
- By:
- Publication type:
- Article
TURANDOT.
- Published in:
- MD Conference Express, 2015, v. 15, n. 14, p. 10, doi. 10.1177/1559897715593916
- By:
- Publication type:
- Article
Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 6, p. 2635, doi. 10.1007/s10620-023-07956-8
- By:
- Publication type:
- Article
Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 6, p. 2658, doi. 10.1007/s10620-023-07825-4
- By:
- Publication type:
- Article
Existing Bowel Preparation Quality Scales Are Reliable in the Setting of Centralized Endoscopy Reading.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 4, p. 1195, doi. 10.1007/s10620-022-07729-9
- By:
- Publication type:
- Article
Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn's Disease.
- Published in:
- Digestive Diseases & Sciences, 2015, v. 60, n. 5, p. 1414, doi. 10.1007/s10620-014-3419-5
- By:
- Publication type:
- Article
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis.
- Published in:
- Crohn's & Colitis 360, 2024, v. 6, n. 1, p. 1, doi. 10.1093/crocol/otae004
- By:
- Publication type:
- Article
Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension Studies.
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 3, p. 1, doi. 10.1093/crocol/otad044
- By:
- Publication type:
- Article
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis.
- Published in:
- Crohn's & Colitis 360, 2021, v. 3, n. 4, p. 1, doi. 10.1093/crocol/otab079
- By:
- Publication type:
- Article
Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
- Published in:
- European Journal of Clinical Investigation, 2011, v. 41, n. 10, p. 1071, doi. 10.1111/j.1365-2362.2011.02502.x
- By:
- Publication type:
- Article
An Open-Label Pilot Study of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Endoscopic Postoperative Recurrence in Crohn’s Disease.
- Published in:
- Digestion, 2003, v. 68, n. 2/3, p. 63, doi. 10.1159/000074517
- By:
- Publication type:
- Article
Sequential Treatment of Anemia in Ulcerative Colitis with Intravenous Iron and Erythropoietin.
- Published in:
- Digestion, 1999, v. 60, n. 3, p. 262, doi. 10.1159/000007667
- By:
- Publication type:
- Article
Course of Pseudocholinesterase Isozymes during an Acute Phase in Crohn's Disease.
- Published in:
- Digestion, 1996, v. 57, n. 2, p. 90, doi. 10.1159/000201319
- By:
- Publication type:
- Article
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 4, p. 277, doi. 10.1007/s40261-023-01252-z
- By:
- Publication type:
- Article
Evidence of colony suppressor activity and deficiency of hematopoietic growth factors in hairy cell leukemia.
- Published in:
- Hematological Oncology, 1993, v. 11, n. 2, p. 97, doi. 10.1002/hon.2900110207
- By:
- Publication type:
- Article
Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment persistence and switching patterns of ABP 501 in European patients with inflammatory bowel disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2024, p. 1, doi. 10.1177/17562848231222332
- By:
- Publication type:
- Article
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 2, p. 224, doi. 10.1002/jcph.1732
- By:
- Publication type:
- Article
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 6, p. 790, doi. 10.1002/jcph.1069
- By:
- Publication type:
- Article
Association of a Functional Variant in the Wnt Co-Receptor LRP6 with Early Onset Ileal Crohn's Disease.
- Published in:
- PLoS Genetics, 2012, v. 8, n. 2, p. 1, doi. 10.1371/journal.pgen.1002523
- By:
- Publication type:
- Article
Three novel thiopurine S-methyltransferase allelic variants ( TPMT* 20, * 21, * 22) - association with decreased enzyme function.
- Published in:
- Human Mutation, 2006, v. 27, n. 9, p. 976, doi. 10.1002/humu.9450
- By:
- Publication type:
- Article
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis—two cases in real world clinical practice. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1209, doi. 10.1111/apt.15735
- By:
- Publication type:
- Article
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 10, p. 1068, doi. 10.1111/apt.15514
- By:
- Publication type:
- Article
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 8, p. 1270, doi. 10.1093/ecco-jcc/jjae038
- By:
- Publication type:
- Article
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 5, p. 708, doi. 10.1093/ecco-jcc/jjad199
- By:
- Publication type:
- Article